ERS Advocacy Council

Advocacy is a core pillar of ERS. The Society’s involvement in advocacy is co-ordinated via the ERS Advocacy Council.

About

Article I of the ERS Constitution outlines a key objective of ERS: to promote respiratory health in order to alleviate suffering from respiratory disease. The Advocacy Council plays an important role in this objective. The Council is constituted via the by-laws of ERS and is comprised of key leaders within the Society.

Objectives
  • Increase resources to manage patient and respiratory health problems; to research respiratory-related disorders; and to promote education for healthcare professionals in respiratory health.
  • Coordinate all matters pertaining to advocacy of the Tobacco Control Committee and the Environment and Health Committee.
  • Link with other organisations to promote awareness for respiratory disorders at national, EU and global level.

Council members

Barbara Hoffmann  - profile image
Barbara Hoffmann
Advocacy Council Chair

Declaration of Interests

Annual Declaration of Interest 2023-2024

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
DFGResearch grantD
Umwelt- und NachbarschaftshausResearch grantD
UmweltbundesamtResearch grantD

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Monika Gappa - profile image
Monika Gappa
ERS President

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
Company Purpose of Payment Amount of funds received*
Aimmune Lecture feeB
NestleLecture feeB
SanofiLecture fee, advisory committeeC
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
InfectopharmClinical trial feesB
ALK AlbelloClinical Trial feesB
NestleUnrestricted grant, investigator initiated researchD
SanofiClinical trial feesC

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Silke Ryan - profile image
Silke Ryan
ERS President Elect

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
FitbitUnrestricted grantD
Novo NordiskUnrestricted grantD

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Joanna Chorostowska-Wynimko - profile image
Joanna Chorostowska-Wynimko
ERS Vice President

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
Company Purpose of Payment Amount of funds received*
MSDlecturesB
Pfizerlectures; advisory committeeB
AstraZenecalectures; advisory committeeB
Takedalectures;B
Amgenlectures;B
Adamedlectures;B
Grifolslectures;B
CSL Behringlectures;advisory committeeB
Mereo Biopharmaadvisory committeeB
Personal Travel Grants or expenses for conferences etc.
Company Purpose and Nature of Benefit Amount of funds received*
MSDconferenceB
AmgenconferenceB
Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
Biocartisdonated to my InstitutionA
Pfizerdonated to my InstitutionB
AstraZenecareserach grant donated to my InstitutionD

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Dimitris Kontopidis - profile image
Dimitris Kontopidis
Chair of the European Lung Foundation

Dimitris is a cystic fibrosis patient and advocate as well as Vice President of the Greek Patient Association, and founder of Patients Hub.

He won the European Lung Foundation (ELF) Award in 2021 for his efforts to ensure equal access to innovative treatments and health services for all.


Filippos Filippidis - profile image
Filippos Filippidis
ERS Tobacco Control Committee Chair

Zorana J. Andersen - profile image
Zorana J. Andersen
Chair of the ERS Environment and Health Committee

Eva Polverino - profile image
Eva Polverino
Director of Scientific Relations with the EU

Judith Garcia Aymerich - profile image
Judith Garcia Aymerich
ERS Secretary General

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
Company Purpose of Payment Amount of funds received*
AZMember of advisory boardB
ChiesiSpeakerA
ChiesiChapter writerA
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
AZResearch project on COVIDC

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Karen Moor - profile image
Karen Moor
ERS Early Career Members Representative

Anita Simonds - profile image
Anita Simonds
ERS Representative to EMA

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
Company Purpose of Payment Amount of funds received*
ResMedSponsorship to attend and present at symposium at World Sleep Congress 2022B
European Medicines Agency Emergency Task Force member - attendance at committee meetingsB
ACI ClinicalMember of Endpoint Committee for bioALS TrialB
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

None

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000

Learn about ERS’s advocacy activities and policy areas

Read more